Biomaterials start-up Elevance has raised $100 million in a Series C funding round, the company announced today. The funding round is the company's third. Naxos Capital partners led the round. Other...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.